Morepen Labs Transfers 9% MML Stake to Business Head

Board approved transfer of 1.62 lakh MML shares to Head - Medical Devices for strategic alignment.
Company's stake in subsidiary Morepen Medipath reduced from 60% to 51% post-transaction.
Transaction consideration was mutually agreed between parties with no financial impact disclosed.
MML will continue as subsidiary and be consolidated in Morepen's financial statements.